Intra-Cellular Therapies to Present at the 9th Annual SVB Leerink Global Healthcare Conference
February 18 2020 - 8:00AM
Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a
biopharmaceutical company focused on the development and
commercialization of therapeutics for central nervous system (CNS)
disorders, today announced that Sharon Mates, Ph.D., Chief
Executive Officer and Chairman, is scheduled to present at the 9th
Annual SVB Leerink Global Healthcare Conference in New York. The
presentation is scheduled for Tuesday, February 25,
2020 at 9:00 am ET.
The live and archived webcast can be accessed under "Press
Releases & Events" in the Investor Relations section of the
Company's website at www.intracellulartherapies.com. Please
log in approximately 5-10 minutes prior to the event to register
and to download and install any necessary software.
About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company
founded on Nobel prize-winning research that allows us to
understand how therapies affect the inner-workings of cells in the
body. The company leverages this intracellular approach to develop
innovative treatments for people living with complex psychiatric
and neurologic diseases. For more information, please
visit www.intracellulartherapies.com.
Contact:
Intra-Cellular Therapies, Inc. Juan Sanchez, M.D. Vice
President, Corporate Communications and Investor Relations
646-440-9333
Burns McClellan, Inc. Lisa Burns jgrimaldi@burnsmc.com
212-213-0006
MEDIA INQUIRIES:
Ana Fullmer Corporate Media Relations W2Owcg
afullmer@wcgworld.com 202-507-0130
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Sep 2023 to Sep 2024